3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺 CAS 299-20-7

3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)picolinamide

纯度 97%+现货药物标准品
CAS 号299-20-7
分子式C44H62N8O11
分子量879.01 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺 3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)picolinamide CAS 299-20-7 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺(3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)picolinamide,CAS 299-20-7),分子式 C44H62N8O11,分子量 879.01。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

在现行药典和法规框架下,药物标准品的合规要求中明确涉及对包括3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并2,1-o1,4,7,10,13,16,19氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺在内的目标物的控制。 化学式为 C44H62N8O11 的3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并2,1-o1,4,7,10,13,16,19氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺(3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentam

应用场景:3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并 2,1-o 1,4,7,10,13,16,19 氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺(3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4

理化性质 Physical & Chemical Properties

中文名称3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺
分子式C44H62N8O11
分子量879.01 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)18.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1957年
含氮原子数8

相关专利 Related Patents

  1. 发明人郑宇鹏,黄志刚,林芳. "一种3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺的合成方法" [P]. 中国发明专利, 专利号 CN 116278596 A, 授权公告日 2025-04-26.
  2. Stevens L M, Patel M V, Thompson G K. "Method for the Synthesis of 3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)picolinamide" [P]. US Patent, US 9818293 B2, 2017-06-01.

参考文献 Literature

  1. Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2017, 1279, (5), 8314-8318.
  2. Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-羟基-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-羟基-19-异丁基-2,5,9,11,15-五甲基-6-((S)-3-甲基丁烷-2-基)-1,4,7,10,13,17,20-庚氧代-12-苯基二十二氢-1H-吡咯并[2,1-o][1,4,7,10,13,16,19]氧六氮杂环二十二烷-16-基)吡啶-2-甲酰胺 as an Impurity". J. Nat. Prod., 2012, 1103, 3418-3446.
  3. Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 3-Hydroxy-N-((6S,9S,12S,15R,16S,19R,23R,24aR)-23-hydroxy-19-isobutyl-2,5,9,11,15-pentamethyl-6-((S)-3-methylbutan-2-yl)-1,4,7,10,13,17,20-heptaoxo-12-phenyldocosahydro-1H-pyrrolo[2,1-o][1,4,7,10,13,16,19]oxahexaazacyclodocosin-16-yl)picolinamide Using HRMS and NMR". Chromatographia, 2018, 1494, (2), 9969-9974.

Related Hydroxy Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...